Navigation Links
PharmAthene Reports First Quarter 2009 Financial and Operational Results
Date:5/15/2009

,348,453 2,502,909 Total assets $53,723,840 $56,391,270 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable $3,409,022 $3,870,871 Accrued expenses and other liabilities 12,197,532 14,624,757 Convertible notes 13,828,776 13,377,505 Current portion of warrants to purchase common stock 377,753 - Current portion of long-term debt 3,947,979 4,000,000 Total current liabilities 33,761,062 35,873,133 Other long-term liabilities 2,230,670 626,851 Warrants to purchase common stock 1,158,031 - Long-term debt - 928,117 Total liabilities 37,149,763 37,427,831 Stockholders' equity: Common stock, $0.0001 par value; 100,000,000 shares authorized; 28,012,031 and 25,890,143 shares issued and outstanding at March 31, 2009 and December 31, 2008; respectively, 2,802 2,589 Additional paid-in capital 146,662,830 142,392,163 Accumulated other comprehensive (loss) income (260,869) 386,351 Accumulated deficit (129,830,686) (123,817,664) Total stockholders' equity 16,574,077 18,963,439 Total liabilities and stockholders' equity $53,723,840 $56,391,270

                                  PHARMATHENE, INC.

                        CONSOLIDATED STATEMENTS OF OPERATIONS

                                           Three months ended March 31,
                                      
'/>"/>
SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
4. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
5. PharmAthene to Present at the BIO CEO & Investor Conference 2008
6. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
7. PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008
8. PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference
9. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
10. PharmAthene to Delay Release of Full Year 2007 Financial Results
11. PharmAthene Year-End 2007 Earnings Conference Call and Webcast Scheduled for Monday, March 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... The first product launch from start-up Hurley Research ... What sets Droidles completely apart from other stand alone ... to communicate, share code with each other and evolve ... invention is the system,” said Hurley Research founder Jay ... their own, both physically and on the internet." Remote ...
(Date:7/29/2014)... The prestigious "Discovery or Exploration in ... awarded to Juliana Hillis and Kaylie O’Connell, students at ... “From an Egg, Everything: America’s First IVF Baby". This ... the National History Day program during a week-long final ... in Washington, D.C. , The growing popularity of the ...
(Date:7/29/2014)... CA (PRWEB) July 29, 2014 ... medical devices, and cloud based eClinical technologies, have been ... Device Online. These follow a long line of white ... profile publications including Life Science Leader, Pharmaceutical Online, and ... Clinovo provided a paper by CTO Marc Desgrousilliers, ...
(Date:7/29/2014)... , July 29, 2014 ... System (LBS) zur Erfassung biologischer Daten in ... entwickelt und patentiert. Das LBS nimmt gleichzeitig ... Koronararterie des Patienten und sucht erhöhte biologische ... das Potenzial, die Entdeckung und Entwicklung neuer ...
Breaking Biology Technology:Droidles, the Social Network of Robots and Open Source Platform for the Internet of Things, Launches for Crowd Funding on IndieGoGo.com 2In Vitro Fertilization (IVF) was the Subject of This Year’s Winning Entry for the Prestigious Library of Congress “Discovery or Exploration in History Award” 2In Vitro Fertilization (IVF) was the Subject of This Year’s Winning Entry for the Prestigious Library of Congress “Discovery or Exploration in History Award” 3Clinovo White Papers Published in Summer 2014 Editions of Leading Medical Device & Pharmaceutical Publications 2Clinovo White Papers Published in Summer 2014 Editions of Leading Medical Device & Pharmaceutical Publications 3PlaqueTec sichert sich CE-Kennzeichnung für Liquid Biopsy System - bahnbrechende Innovation zur Erfassung neuer biologischer Informationen aus erkranktem Herzkranzgefäß 2PlaqueTec sichert sich CE-Kennzeichnung für Liquid Biopsy System - bahnbrechende Innovation zur Erfassung neuer biologischer Informationen aus erkranktem Herzkranzgefäß 3PlaqueTec sichert sich CE-Kennzeichnung für Liquid Biopsy System - bahnbrechende Innovation zur Erfassung neuer biologischer Informationen aus erkranktem Herzkranzgefäß 4
... Prepare for Zingo Launch ... Promoted To Senior Vice President, Marketing and Sales, and ... - Additional Manufacturing Capacity in China -, - Details to be Presented at Investor Briefing Today at ... Time -, ...
... TPPII may contribute to obesity by stimulating the formation of ... The enzyme, TPPII, has previously been linked to making people ... it may be even more deeply involved in causing obesity. ... of fat cells in worms and mammalian cells and that ...
... Ill. New sol-gel inks developed by researchers at ... to produce three-dimensional structures of metal oxides with nanoscale ... at the nanoscale opens a new avenue to functional ... gas sensors., The researchers describe the new inks in ...
Cached Biology Technology:Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 2Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 3Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 4Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 5Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 6Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 7Sol-gel inks produce complex shapes with nanoscale features 2
(Date:7/28/2014)... Reactions among minerals and organic compounds in hydrothermal environments ... they provide energy for the deep biosphere, and may ... little is known about how minerals influence organic reactions. ... have demonstrated how a common mineral acts as a ... need for toxic solvents or expensive reagents. , At ...
(Date:7/28/2014)... 10 U.S. cities that have seen an increase in ... road closures, overwhelmed storm drains and compromised infrastructure--are on ... report. , This nuisance flooding, caused by rising sea ... 300 and 925 percent since the 1960s. , The ... around the United States, also finds Annapolis and Baltimore, ...
(Date:7/28/2014)... study found that 73 percent of adult survivors of ... metabolic syndrome and related health problems by failing to ... current issue of the journal Cancer . , ... childhood cancer in the study had metabolic syndrome, an ... pressure, abdominal obesity, elevated triglyceride and other abnormalities that ...
Breaking Biology News(10 mins):Mineral magic? Common mineral capable of making and breaking bonds 2Mineral magic? Common mineral capable of making and breaking bonds 3NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 2NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 3Unhealthy habits more than double risk of metabolic syndrome in childhood cancer survivors 2Unhealthy habits more than double risk of metabolic syndrome in childhood cancer survivors 3
... Md., Sept. 19, 2012  BioFortis Inc., a leading ... research space, today introduced its Next Generation ... It will help pharmaceutical, government and academic ... translational studies to safely and effectively conduct ...
... Va.Dr. John P. Holdren, White House Office of Science ... roster of military and government leaders at the Office ... and ASNE Expo, officials announced Sept. 18. Holdren, ... and co-chair of the President,s Council of Advisors on ...
... residents with disabilities, along with their families, can look ... Developmental Disabilities Institute (DDI) at Wayne State University. ... from the U.S. Administration for Children and Families. ... contributing to the development of inclusive communities and quality ...
Cached Biology News:BioFortis Inc., Introduces Next Generation Biobanking Software Platform for Biomarker-Based Clinical Research 2ONR lines up speakers and technologies for 2012 Naval Conference 2Wayne State receives $2.8 million grant from US Administration for Children and Families 2Wayne State receives $2.8 million grant from US Administration for Children and Families 3
... Our Accumix standard is a new tuning ... electrospray ionization mass spectrometry. Accumix is ... mass range coverage for both tuning and ... and LTQ-MS) and Fourier transform mass spectrometers. ...
Determine relative degree of protein binding to phosphoinositides...
... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
Goat polyclonal to STMN2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: AKTAMAYKEK, corresponding to C terminal amino acids 2-11 of STMN2. Entrez Gene ID: 11075 Swi...
Biology Products: